Benjamin Scheier

982 total citations · 1 hit paper
6 papers, 742 citations indexed

About

Benjamin Scheier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Benjamin Scheier has authored 6 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Molecular Biology. Recurrent topics in Benjamin Scheier's work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (3 papers) and Melanoma and MAPK Pathways (1 paper). Benjamin Scheier is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (3 papers) and Melanoma and MAPK Pathways (1 paper). Benjamin Scheier collaborates with scholars based in United States and Australia. Benjamin Scheier's co-authors include Gregory N. Gan, Laurie E. Gaspar, Andrew Weickhardt, Brian D. Kavanagh, D. Ross Camidge, Robert C. Doebele, Joseph Burke, Paul A. Bunn, Xian Lu and Dara L. Aisner and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Journal of Thoracic Oncology.

In The Last Decade

Benjamin Scheier

6 papers receiving 730 citations

Hit Papers

Local Ablative Therapy of Oligoprogressive Disease Prolon... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
    2012 508 citations Andrew Weickhardt, Benjamin Scheier et al. Journal of Thoracic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Scheier United States 5 650 547 127 83 59 6 742
S-H.I. Ou United States 9 515 0.8× 372 0.7× 140 1.1× 93 1.1× 80 1.4× 34 642
J. Le Treut France 10 701 1.1× 496 0.9× 91 0.7× 112 1.3× 84 1.4× 22 898
Augusto Villegas Spain 12 608 0.9× 628 1.1× 66 0.5× 59 0.7× 152 2.6× 27 851
Anna-Larissa N. Niemeijer Netherlands 9 457 0.7× 805 1.5× 60 0.5× 68 0.8× 238 4.0× 15 988
Jessamy A. Boyd United States 8 590 0.9× 319 0.6× 73 0.6× 97 1.2× 139 2.4× 10 728
Hisao Uejima Japan 11 374 0.6× 371 0.7× 127 1.0× 35 0.4× 44 0.7× 22 549
Y. Nakanishi Japan 6 440 0.7× 233 0.4× 109 0.9× 118 1.4× 86 1.5× 7 613
Akira Hamada Japan 12 374 0.6× 206 0.4× 166 1.3× 74 0.9× 64 1.1× 63 575
Hiroshi Suehisa Japan 14 877 1.3× 493 0.9× 288 2.3× 239 2.9× 146 2.5× 38 1.1k
Natascha A. J. B. Peters Netherlands 8 310 0.5× 392 0.7× 64 0.5× 263 3.2× 49 0.8× 20 547

Countries citing papers authored by Benjamin Scheier

Since Specialization
Citations

This map shows the geographic impact of Benjamin Scheier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Scheier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Scheier more than expected).

Fields of papers citing papers by Benjamin Scheier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Scheier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Scheier. The network helps show where Benjamin Scheier may publish in the future.

Co-authorship network of co-authors of Benjamin Scheier

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Scheier. A scholar is included among the top collaborators of Benjamin Scheier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Scheier. Benjamin Scheier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Scheier, Benjamin, et al.. (2016). Metastatic Merkel cell carcinoma response to nivolumab. Journal for ImmunoTherapy of Cancer. 4(1). 79–79. 35 indexed citations
2.
Scheier, Benjamin, Christopher D. Lao, Kelley M. Kidwell, & Bruce G. Redman. (2015). Utility of pre-operative PET/CT staging in sentinel lymph node-positive melanoma.. Journal of Clinical Oncology. 33(15_suppl). 6566–6566. 1 indexed citations
3.
Gan, Gregory N., Andrew Weickhardt, Benjamin Scheier, et al.. (2014). Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib. International Journal of Radiation Oncology*Biology*Physics. 88(4). 892–898. 168 indexed citations
4.
Weickhardt, Andrew, Benjamin Scheier, Joseph Burke, et al.. (2012). Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(12). 1807–1814. 508 indexed citations breakdown →
5.
Weickhardt, Andrew, Benjamin Scheier, Joseph Burke, et al.. (2012). Continuation of EGFR/ALK inhibition after local therapy of oligoprogressive disease in EGFR mutant (Mt) and ALK+ non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 30(15_suppl). 7526–7526. 17 indexed citations
6.
Scheier, Benjamin, Rodabe N. Amaria, Karl D. Lewis, & René González. (2011). Novel Therapies in Melanoma. Immunotherapy. 3(12). 1461–1469. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S-H.I. Ou Breakdown of academic impact, for papers by J. Le Treut Breakdown of academic impact, for papers by Augusto Villegas Breakdown of academic impact, for papers by Anna-Larissa N. Niemeijer Breakdown of academic impact, for papers by Jessamy A. Boyd Breakdown of academic impact, for papers by Hisao Uejima Breakdown of academic impact, for papers by Y. Nakanishi Breakdown of academic impact, for papers by Akira Hamada Breakdown of academic impact, for papers by Hiroshi Suehisa Breakdown of academic impact, for papers by Natascha A. J. B. Peters
Rankless by CCL
2026